T1	CHEM 70 79	rucaparib
#1	AnnotatorNotes T1	C3661315; rucaparib; Organic Chemical · Pharmacologic Substance
T2	CHEM 230 239	rucaparib
#2	AnnotatorNotes T2	C3661315; rucaparib; Organic Chemical · Pharmacologic Substance
T3	DISO 97 127	cáncer de próstata metastásico
T4	ANAT 1634 1650	gastrointestinal
#3	AnnotatorNotes T4	C0012240; Gastrointestinal system; Body System
T5	PROC 144 154	castración
#4	AnnotatorNotes T5	C0007344; Castration; Therapeutic or Preventive Procedure
T6	PROC 186 226	Estudio fase II, multicéntrico y abierto
T7	DISO 257 287	cáncer de próstata metastásico
T8	ANAT 1652 1654	GI
T9	PROC 304 314	castración
#5	AnnotatorNotes T9	C0007344; Castration; Therapeutic or Preventive Procedure
T10	DISO 389 407	cáncer de próstata
#6	AnnotatorNotes T10	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T11	DISO 443 473	cáncer de próstata metastásico
T12	PROC 584 608	consentimiento informado
#7	AnnotatorNotes T12	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T13	PROC 490 500	castración
#8	AnnotatorNotes T13	C0007344; Castration; Therapeutic or Preventive Procedure
T14	DISO 618 632	adenocarcinoma
#9	AnnotatorNotes T14	C0001418; Adenocarcinoma; Neoplastic Process
T15	DISO 635 662	carcinoma poco diferenciado
#10	AnnotatorNotes T15	C0741899; Poorly differentiated carcinoma; Neoplastic Process
T16	CHEM 1738 1747	rucaparib
#11	AnnotatorNotes T16	C3661315; rucaparib; Organic Chemical · Pharmacologic Substance
T17	PROC 733 771	castrado quirúrgicamente o médicamente
T18	CHEM 788 800	testosterona
#12	AnnotatorNotes T18	C0039601; testosterone; Hormone · Organic Chemical · Pharmacologic Substance
T19	ANAT 804 809	suero
#13	AnnotatorNotes T19	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T20	DISO 838 865	Progresión de la enfermedad
#14	AnnotatorNotes T20	C0242656; Disease Progression; Pathologic Function
T21	PROC 874 885	tratamiento
#15	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	PROC 920 952	tratamientos de nueva generación
T23	CHEM 966 968	RA
#16	AnnotatorNotes T23	C0034786; Androgen Receptor; Amino Acid, Peptide, or Protein · Receptor
T24	PROC 974 987	quimioterapia
#17	AnnotatorNotes T24	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T25	CHEM 999 1005	taxano
#18	AnnotatorNotes T25	C0796419; Taxanes; Organic Chemical
T26	DISO 1014 1024	enfermedad
#19	AnnotatorNotes T26	C0012634; Disease; Disease or Syndrome
T27	PROC 1041 1051	castración
#20	AnnotatorNotes T27	C0007344; Castration; Therapeutic or Preventive Procedure
T28	DISO 1221 1238	Neoplasia maligna
#21	AnnotatorNotes T28	C0006826; Malignant Neoplasms; Neoplastic Process
T29	DISO 1262 1296	cáncer de piel de tipo no melanoma
#22	AnnotatorNotes T29	C0699893; Skin carcinoma; Neoplastic Process
T31	DISO 1061 1079	mutación deletérea
T32	DISO 1325 1342	carcinoma in situ
#24	AnnotatorNotes T32	C0007099; Carcinoma in Situ; Neoplastic Process | C0851135; In situ cancer; Neoplastic Process
T33	DISO 1345 1373	cáncer superficial de vejiga
T34	ANAT 1367 1373	vejiga
#25	AnnotatorNotes T34	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T35	PROC 1377 1388	Tratamiento
#26	AnnotatorNotes T35	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T36	CHEM 1410 1430	inhibidor de la PARP
#27	AnnotatorNotes T36	C1882413; Poly(ADP-ribose) Polymerase Inhibitors; Organic Chemical · Pharmacologic Substance
T37	CHEM 1432 1444	mitoxantrona
#28	AnnotatorNotes T37	C0026259; mitoxantrone; Organic Chemical · Pharmacologic Substance
T38	CHEM 1446 1460	ciclofosfamida
#29	AnnotatorNotes T38	C0010583; cyclophosphamide; Organic Chemical · Pharmacologic Substance
T39	PROC 1473 1486	quimioterapia
#30	AnnotatorNotes T39	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T40	DISO 1502 1525	Metástasis sintomáticas
T41	ANAT 1546 1570	sistema nervioso central
#31	AnnotatorNotes T41	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T42	ANAT 1588 1596	duodenal
#32	AnnotatorNotes T42	C0013303; Duodenum; Body Part, Organ, or Organ Component
T43	DISO 1624 1650	trastorno gastrointestinal
#33	AnnotatorNotes T43	C0017178; Gastrointestinal Diseases; Disease or Syndrome
T44	DISO 1658 1665	defecto
#34	AnnotatorNotes T44	C0231172; handicapping condition; Finding
T45	ANAT 107 115	próstata
#35	AnnotatorNotes T45	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T46	ANAT 267 275	próstata
#36	AnnotatorNotes T46	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T47	DISO 328 365	deficiencia de recombinación homóloga
#37	AnnotatorNotes T47	C4049599; Homologous Recombination Deficiency; Cell or Molecular Dysfunction
T48	ANAT 399 407	próstata
#38	AnnotatorNotes T48	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T49	ANAT 453 461	próstata
#39	AnnotatorNotes T49	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T50	ANAT 666 674	próstata
#40	AnnotatorNotes T50	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T51	PROC 777 809	niveles de testosterona en suero
T52	DISO 1145 1182	deficiencia de recombinación homóloga
#41	AnnotatorNotes T52	C4049599; Homologous Recombination Deficiency; Cell or Molecular Dysfunction
T53	ANAT 1272 1276	piel
#42	AnnotatorNotes T53	C1123023; Skin; Body System | C1278993; Entire skin; Body System
T54	CHEM 1491 1498	platino
#43	AnnotatorNotes T54	C0032207; platinum; Element, Ion, or Isotope
T55	PROC 1533 1541	tratadas
#44	AnnotatorNotes T55	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T56	PROC 1575 1596	Endoprótesis duodenal
T57	Date 13 17	2016
T58	LIVB 83 92	pacientes
#45	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	LIVB 243 252	pacientes
#46	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	PHYS 343 365	recombinación homóloga
#47	AnnotatorNotes T60	C0599773; Homologous Recombination; Genetic Function
T61	Age 527 534	18 años
T62	LIVB 724 732	Paciente
#48	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T64	LIVB 1098 1106	cohortes
#49	AnnotatorNotes T64	C0599755; Cohort; Population Group
T65	PHYS 1160 1182	recombinación homóloga
#50	AnnotatorNotes T65	C0599773; Homologous Recombination; Genetic Function
T66	LIVB 1184 1191	cohorte
#51	AnnotatorNotes T66	C0599755; Cohort; Population Group
T67	Neg_cue 1247 1261	a excepción de
T69	Neg_cue 1530 1532	no
T70	DEVI 1575 1587	Endoprótesis
#52	AnnotatorNotes T70	C0038257; Stent, device; Medical Device
T71	LIVB 1686 1698	investigador
#53	AnnotatorNotes T71	C0035173; Research Personnel; Professional or Occupational Group
T63	GENE 1083 1090	BRCA1/2
T72	GENE 1093 1096	ATM
#55	AnnotatorNotes T72	C0919524; ATM gene; Gene or Genome
T73	PROC 1297 1304	tratado
#56	AnnotatorNotes T73	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T74	PHYS 1725 1734	absorción
#57	AnnotatorNotes T74	C0678745; drug absorption; Physiologic Function
T75	PROC 695 706	histológica
#58	AnnotatorNotes T75	C0344441; Histology Procedure; Laboratory Procedure
T76	PROC 709 719	citológica
#59	AnnotatorNotes T76	C1305671; Cytology procedure; Laboratory Procedure
A1	Assertion T29 Negated
A3	Assertion T55 Negated
A5	Status T24 History_of
A6	Status T25 History_of
A4	Status T35 History_of
A7	Status T36 History_of
A8	Status T37 History_of
A9	Status T38 History_of
A10	Status T39 History_of
A11	Status T54 History_of
A12	Status T56 History_of
A13	Status T70 History_of
#60	AnnotatorNotes T6	C0282460; Phase 2 Clinical Trials; Research Activity + C1096776; Multicenter Study; Research Activity + C1709323; Open Label Study; Research Activity 
#61	AnnotatorNotes T7	C0936223; Metastatic Prostate Carcinoma; Neoplastic Process
#62	AnnotatorNotes T3	C0936223; Metastatic Prostate Carcinoma; Neoplastic Process
#63	AnnotatorNotes T11	C0936223; Metastatic Prostate Carcinoma; Neoplastic Process
#64	AnnotatorNotes T51	C0428413; Serum testosterone measurement; Laboratory Procedure 
#65	AnnotatorNotes T31	C2985436; Deleterious Mutation; Cell or Molecular Dysfunction
#54	AnnotatorNotes T33	C1336527; Carcinoma of urinary bladder, superficial; Neoplastic Process
#66	AnnotatorNotes T8	C0012240; Gastrointestinal system; Body System
#67	AnnotatorNotes T63	C0376571; BRCA1 gene; Gene or Genome | C0598034; BRCA2 gene; Gene or Genome
T77	Quantifier_or_Qualifier 890 900	al menos 1
T78	Neg_cue 907 909	no
T79	Quantifier_or_Qualifier 910 918	más de 2
A14	Assertion T79 Negated
T80	Spec_cue 1700 1706	podría
T81	CONC 1707 1717	interferir
A15	Assertion T81 Speculated
#68	AnnotatorNotes T81	C0521102; Interferes with; Functional Concept
R1	Experiences Arg1:T58 Arg2:T1	
R2	Location_of Arg1:T45 Arg2:T3	
R3	Experiences Arg1:T58 Arg2:T3	
R4	Experiences Arg1:T58 Arg2:T5	
T30	Observation 128 154	resistente a la castración
#23	AnnotatorNotes T30	C4329620; Castration Resistance; Finding
R5	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T30	
R8	Location_of Arg1:T46 Arg2:T7	
T68	Observation 288 314	resistente a la castración
#69	AnnotatorNotes T68	C4329620; Castration Resistance; Finding
R9	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T68	
R11	Experiences Arg1:T59 Arg2:T2	
R12	Experiences Arg1:T59 Arg2:T7	
R14	Experiences Arg1:T59 Arg2:T9	
R15	Experiences Arg1:T59 Arg2:T47	
R16	Experiences Arg1:T59 Arg2:T60	
R17	Overlap Arg1:T7 Arg2:T47	
R19	Overlap Arg1:T68 Arg2:T47	
R20	Location_of Arg1:T48 Arg2:T10	
R21	Location_of Arg1:T49 Arg2:T11	
T82	Observation 474 500	resistente a la castración
#70	AnnotatorNotes T82	C4329620; Castration Resistance; Finding
R22	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T82	
T83	Quantifier_or_Qualifier 408 416	avanzado
#71	AnnotatorNotes T83	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R24	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T83	
R25	Overlap Arg1:T12 Arg2:T61	
R26	Location_of Arg1:T50 Arg2:T15	
R27	Location_of Arg1:T50 Arg2:T14	
R32	Experiences Arg1:T62 Arg2:T17	
R33	Experiences Arg1:T62 Arg2:T51	
T84	Result_or_Value 810 834	< o = 50 ng/dl (1,73 nM)
R35	Location_of Arg1:T19 Arg2:T51	
R36	Has_Result_or_Value Arg1:T51 Arg2:T84	
R37	After Arg1:T20 Arg2:T21	
R38	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T77	
R39	Negation Arg1:T78 Arg2:T79	
R40	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T79	
R41	After Arg1:T20 Arg2:T22	
T85	Quantifier_or_Qualifier 953 968	dirigidos al RA
R42	After Arg1:T20 Arg2:T24	
R43	Used_for Arg1:T25 Arg2:T24	
R44	Before Arg1:T26 Arg2:T20	
T86	Observation 1025 1051	resistente a la castración
R45	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T86	
#72	AnnotatorNotes T86	C4329620; Castration Resistance; Finding
R47	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T85	
R48	Location_of Arg1:T63 Arg2:T31	
R49	Location_of Arg1:T72 Arg2:T31	
R50	Experiences Arg1:T64 Arg2:T31	
R51	Experiences Arg1:T66 Arg2:T52	
R52	Experiences Arg1:T66 Arg2:T65	
R53	Negation Arg1:T67 Arg2:T29	
R54	Location_of Arg1:T53 Arg2:T29	
T87	Quantifier_or_Qualifier 1239 1245	activa
#73	AnnotatorNotes T87	C0679217; Active State; Idea or Concept
R55	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T87	
T88	Quantifier_or_Qualifier 1305 1323	de manera curativa
R56	Has_Quantifier_or_Qualifier Arg1:T73 Arg2:T88	
R57	Location_of Arg1:T34 Arg2:T33	
A2	Assertion T32 Negated
R58	Negation Arg1:T67 Arg2:T32	
A16	Assertion T33 Negated
R59	Negation Arg1:T67 Arg2:T33	
R60	Used_for Arg1:T36 Arg2:T35	
R62	Used_for Arg1:T37 Arg2:T35	
R61	Used_for Arg1:T38 Arg2:T35	
R63	Used_for Arg1:T54 Arg2:T39	
R64	Negation Arg1:T69 Arg2:T55	
R65	Location_of Arg1:T41 Arg2:T40	
R66	Used_for Arg1:T70 Arg2:T56	
R67	Location_of Arg1:T42 Arg2:T56	
R68	Location_of Arg1:T4 Arg2:T43	
R69	Location_of Arg1:T8 Arg2:T43	
R70	Speculation Arg1:T80 Arg2:T81	
R74	Used_for Arg1:T16 Arg2:T74	
R75	Before Arg1:T56 Arg2:T74	
R76	Before Arg1:T43 Arg2:T74	
R77	Before Arg1:T44 Arg2:T74	
#74	AnnotatorNotes T88	C1880198; Cure (remedy); Conceptual Entity
A17	Experiencer T71 Other
A18	Experiencer T66 Patient
A19	Experiencer T64 Patient
A20	Experiencer T62 Patient
A21	Experiencer T59 Patient
A22	Experiencer T58 Patient
